News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,297 Results
Type
Article (1941)
Company Profile (2)
Press Release (68354)
Section
Business (21542)
Career Advice (9)
Deals (4566)
Drug Delivery (1)
Drug Development (8173)
FDA (1810)
Job Trends (803)
News (37140)
Policy (3586)
Tag
Academia (93)
Allergies (5)
Alliances (8158)
ALS (6)
Alzheimer's disease (125)
Antibody-drug conjugate (ADC) (13)
Approvals (1841)
Artificial intelligence (14)
Automation (1)
Bankruptcy (8)
Best Places to Work (586)
Biosimilars (22)
Biotechnology (5)
Bladder cancer (11)
Brain cancer (2)
Breast cancer (22)
Cancer (227)
Cardiovascular disease (5)
Career advice (9)
CAR-T (4)
Cell therapy (26)
Clinical research (7049)
Collaboration (96)
Compensation (10)
Complete response letters (2)
COVID-19 (189)
C-suite (17)
Cystic fibrosis (4)
Data (209)
Depression (1)
Diabetes (15)
Diagnostics (599)
Digital health (1)
Drug discovery (13)
Duchenne muscular dystrophy (13)
Earnings (7707)
Events (7037)
Executive appointments (49)
FDA (1975)
Fibrodysplasia Ossificans Progressiva (1)
Funding (61)
Gene editing (3)
Gene therapy (19)
GLP-1 (48)
Government (238)
Grass and pollen (1)
Guidances (14)
Healthcare (1078)
IgA nephropathy (4)
Immunology and inflammation (1)
Indications (3)
Infectious disease (196)
Inflammatory bowel disease (17)
Influenza (6)
Intellectual property (18)
IPO (1638)
Job creations (243)
Job search strategy (9)
Layoffs (6)
Legal (954)
Liver cancer (17)
Lung cancer (37)
Lymphoma (15)
Manufacturing (32)
MASH (8)
Medical device (1126)
Medtech (1127)
Mergers & acquisitions (3027)
Metabolic disorders (42)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (7)
Neuroscience (171)
NextGen: Class of 2025 (221)
Non-profit (62)
Obesity (18)
Opinion (2)
Ovarian cancer (10)
Pain (5)
Pancreatic cancer (8)
Parkinson's disease (15)
Partnered (2)
Patents (20)
Patient recruitment (9)
People (4990)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1913)
Phase II (2957)
Phase III (2667)
Pipeline (139)
Postmarket research (242)
Preclinical (669)
Press Release (2)
Prostate cancer (8)
Radiopharmaceuticals (22)
Rare diseases (27)
Real estate (601)
Regulatory (2626)
Reports (6)
Research institute (92)
Schizophrenia (7)
Series A (15)
Series B (7)
Service/supplier (1)
Sickle cell disease (1)
Spinal muscular atrophy (4)
Startups (422)
Stomach cancer (1)
Supply chain (8)
Vaccines (24)
Venture capitalists (2)
Weight loss (4)
Women's health (1)
Date
Last 7 days (71)
Last 30 days (246)
Last 365 days (2867)
2025 (973)
2024 (3259)
2023 (3822)
2022 (7042)
2021 (6414)
2020 (5934)
2019 (3888)
2018 (3014)
2017 (3569)
2016 (3185)
2015 (4046)
2014 (3025)
2013 (2604)
2012 (2784)
2011 (2904)
2010 (2663)
Location
Africa (83)
Alabama (1)
Arizona (8)
Asia (21460)
Australia (2433)
California (370)
Canada (227)
China (170)
Colorado (4)
Connecticut (15)
Delaware (4)
Europe (12504)
Florida (22)
Georgia (8)
Illinois (18)
India (13)
Indiana (4)
Japan (87)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (78)
Massachusetts (252)
Michigan (2)
Minnesota (27)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (211)
New York (153)
North Carolina (61)
Northern California (146)
Ohio (2)
Oregon (1)
Pennsylvania (58)
South America (106)
Southern California (172)
Tennessee (1)
Texas (28)
United States (1378)
Utah (13)
Virginia (26)
Washington D.C. (2)
Washington State (17)
Wisconsin (6)
70,297 Results for "cipla ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla).
May 20, 2024
·
3 min read
Press Releases
Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension
March 18, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Business
Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives
Pulmatrix today announced that it has entered into a further amendment to its agreement with Cipla for the development of PUR1900 in the treatment of Allergic Bronchopulmonary Aspergillosis (ABPA).
January 8, 2024
·
6 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Showcases Five Innovative Cancer Therapies at 2025 AACR Annual Meeting
May 7, 2025
·
2 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
1 of 7,030
Next
